Logotype for Eisai Co Ltd

Eisai (4523) investor relations material

Eisai Q2 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Eisai Co Ltd
Q2 2026 earnings summary5 Nov, 2025

Executive summary

  • Revenue and profits increased year-over-year, driven by strong growth in the pharmaceutical business, especially from LEQEMBI, LENVIMA, and DAYVIGO, with organic business as the main driver.

  • Operating profit rose 23.6% year-over-year to ¥34.4 billion, supported by effective cost control and declining R&D expenses after the peak of LEQEMBI clinical studies.

  • Comprehensive income for the period was ¥37.3 billion, a significant turnaround from a loss in the prior year.

  • No revision to the full-year forecast, maintaining confidence in achieving ¥54.5 billion operating profit, with further R&D investments and structural reforms expected.

  • Major investments continue in next-generation neurology projects and structural reforms in Europe.

Financial highlights

  • Consolidated revenue for April–September 2025 was ¥400.0 billion, up 3.9% year-over-year; pharmaceutical business revenue grew 5.4% to ¥393.3 billion.

  • Gross profit margin was 78.0%, with gross profit at ¥311.9 billion.

  • R&D expenses were 18.9% of revenue, kept below 20%, and decreased 7.6% year-over-year to ¥75.5 billion.

  • Operating profit margin improved to 8.6%.

  • EPS rose 14.8% year-over-year to ¥87.37.

Outlook and guidance

  • Full-year revenue forecast is ¥790.0 billion, with 50.6% progress achieved in the first half; LEQEMBI forecast remains at ¥76.5 billion.

  • No change to the full-year operating profit forecast of ¥54.5 billion, with most profit expected from organic business.

  • Earnings per share for FY2025 is projected at ¥147.20.

  • Confident in achieving ROE of 8% next year, aiming for double-digit ROE in the future.

  • Profit attributable to owners of the parent for FY2025 is forecast at ¥41.5 billion (down 10.6%).

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Eisai earnings date

Logotype for Eisai Co Ltd
Status Update9 Dec, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Eisai earnings date

Logotype for Eisai Co Ltd
Status Update9 Dec, 2025

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Eisai Co., Ltd. is a global pharmaceutical company based in Tokyo, Japan. The company focuses on the research and development, manufacturing, and marketing of prescription medicines. Eisai's business activities extend to the discovery, development, manufacture, and sale of pharmaceuticals, including a broad range of therapeutic areas such as neurology and oncology. Eisai is headquartered in Bunkyo-ku, Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage